Gail M. Farfel - 23 Aug 2023 Form 4 Insider Report for ProMIS Neurosciences Inc. (PMN)

Role: Chief Executive Officer, Director
Signature: /s/ Max A. Milbury, Attorney-in-Fact for Gail M. Farfel
Issuer symbol: PMN
Transactions as of: 23 Aug 2023
Net transactions value: $0
Form type: 4
Filing time: 25 Aug 2023, 16:19:41 UTC
Previous filing: 23 Jun 2023
Next filing: 27 Sep 2024
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	PMN	Common Shares	Award		+53,192	+2660%		55,192	23 Aug 2023	Direct	F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	PMN	Warrants to purchase Common Shares	Award		+53,192			53,192	23 Aug 2023	Common Shares	53,192	$1.75	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	On August 23, 2023, pursuant to a Unit Purchase Agreement entered into by the Company with selected investors (the "Offering"), the Reporting Person acquired 53,192 common share units (each, a "Common Share Unit"), each unit consisting of one of the Company's common shares, no par value (the "Common Shares"), and one warrant to purchase one Common Share. The purchase price for each Common Share Unit was $1.88 per Common Share Unit.

Content

On August 23, 2023, pursuant to a Unit Purchase Agreement entered into by the Company with selected investors (the "Offering"), the Reporting Person acquired 53,192 common share units (each, a "Common Share Unit"), each unit consisting of one of the Company's common shares, no par value (the "Common Shares"), and one warrant to purchase one Common Share. The purchase price for each Common Share Unit was $1.88 per Common Share Unit.